Outcome after first relapse in childhood acute lymphoblastic leukaemia - Lessons from the United Kingdom R2 trial

British Journal of Haematology

Volumn 130, Issue 1, 2005, Pages 67-75

  Roy, Anindita ^a   Cargill, Anna ^b   Love, S ^b   Moorman, Anthony V ^c   Stoneham, Sara ^a   Lim, Anita ^a   Darbyshire, Phil J ^d   Lancaster, Donna ^e   Hann, Ian ^f   Eden, Tim ^g   Saha, Vaskar ^a,h  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^e ROYAL MARSDEN HOSPITAL   (United Kingdom)

^f GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^g MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^h QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Childhood leukaemia; Leukaemia trials; Relapse; Risk factors

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; BCR ABL PROTEIN; PREDNISOLONE; TRANSCRIPTION FACTOR RUNX1; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; CLINICAL PROTOCOL; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HIGH RISK PATIENT; HUMAN; IMMUNOPHENOTYPING; KAPLAN MEIER METHOD; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL ANALYSIS; SURVIVAL RATE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; BONE MARROW TRANSPLANTATION; CHILD; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; EPIRUBICIN; FEMALE; GREAT BRITAIN; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; PREDNISOLONE; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; VINCRISTINE;

COLD-REDUCTION; MARTENSITIC ALLOYS; RING-CORE; TRANSMUTATION;

DEFORMATION; FISSION PRODUCTS; MARTENSITE; NEUTRON DIFFRACTION; NUCLEAR FUELS; POSITRON ANNIHILATION SPECTROSCOPY; RADIOACTIVITY;

RESIDUAL STRESSES;

EID: 30644480436     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05572.x     Document Type: Article

References (57)

1. Asakura, K., Uchida, H., Miyachi, H., Kobayashi, H., Miyakawa, Y., Nimer, S.D., Takahashi, H., Ikeda, Y. & Kizaki, M. (2004) TEL/ AML1 overcomes drug resistance through transcriptional repression of multidrug resistance-1 gene expression. Molecular Cancer Research, 2, 339-347.
2. Bader, P., Hancock, J., Kreyenberg, H., Goulden, N.J., Niethammer, D., Oakhill, A., Steward, G.G., Handgretinger, R., Beck, J.F. & Klingebiel, T. (2002) Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL. Leukemia, 16, 1668-1672.
3. Bader, P., Kreyenberg, H., Hoelle, W., Dueckers, G., Handgretinger, R., Lang, P., Kremens, B., Dilloo, D., Sykora, K.W., Schrappe, M., Niemeyer, C., Von Stackelberg, A., Gruhn, B., Henze, G., Greil, J., Niethammer, D., Dietz, K., Beck, J.F. & Klingebiel, T. (2004) Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy? Journal of Clinical Oncology, 22, 1696-1705.
4. Barrett, A.J., Horowitz, M.M., Pollock, B.H., Zhang, M.J., Bortin, M.M., Buchanan, G.R., Camitta, B.M., Ochs, J., Graham-Pole, J., Rowlings, P.A., Rimm, A.A., Klein, J.P., Shuster, J.J., Sobocinski, K.A. & Gale, R.P. (1994) Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. New England Journal of Medicine, 331, 1253-1258.
5. Borgmann, A., Baumgarten, E., Schmid, H., Dopfer, R., Ebell, W., Gobel, U., Niethammer, D., Gadner, H. & Henze, G. (1997) Allogeneic bone marrow transplantation for a subset of children with acute lymphoblastic leukemia in third remission: a conceivable alternative? Bone Marrow Transplantation, 20, 939-944.
6. Borgmann, A., von Stackelberg, A., Hartmann, R., Ebell, W., Klingebiel, T., Peters, C. & Henze, G. (2003) Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: a matched-pair analysis. Blood, 101, 3835-3839.
7. Borowitz, M.J., Pullen, D.J., Shuster, J.J., Viswanatha, D., Montgomery, K., Willman, C.L. & Camitta, B. (2003) Minimal residual disease detection in childhood precursor-B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children's Oncology Group study. Leukemia, 17, 1566-1572.
8. Boulad, F., Steinherz, P., Reyes, B., Heller, G., Gillio, A.P., Small, T.N., Brochstein, J.A., Kernan, N.A. & O'Reilly, R.J. (1999) Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission: a single-institution study. Journal of Clinical Oncology, 17, 197-207.
9. Chessells, J., Leiper, A. & Rogers, D. (1984) Outcome following late marrow relapse in childhood acute lymphoblastic leukemia. Journal of Clinical Oncology, 2, 1088-1091.
10. Chessells, J.M., Bailey, G.G. & Richards, S. (1992) MRC UKALL X. The UK protocol for childhood ALL: 1985-1990. The Medical Research Council Working Party on Childhood Leukaemia. Leukemia, 6(Suppl. 2), 157-161.
11. Chessells, J.M., Veys, P., Kempski, H., Henley, P., Leiper, A., Webb, D. & Hann, I.M. (2003) Long-term follow-up of relapsed childhood acute lymphoblastic leukaemia. British Journal of Haematology, 123, 396-405.
12. Clavio, M., Venturino, C., Pierri, I., Garrone, A., Miglino, M., Canepa, L., Balleari, E., Balocco, M., Michelis, G.L., Ballerini, F. & Gobbi, M. (2004) Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia. Annals of Hematology, 83, 696-703.
13. Dopfer, R., Henze, G., Bender-Gotze, C., Ebell, W., Ehninger, G., Friedrich, W., Gadner, H., Klingebiel, T., Peters, C., Riehm, H., Suttorp, M., Schmid, H., Schmilz, N., Siegert, W., Stollmann-Gibbels, B., Hartmann, R. & Niethammer, D. (1991) Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study. Blood, 78, 2780-2784.
14. Eckert, C., Biondi, A., Seeger, K., Cazzaniga, G., Hartmann, R., Beyermann, B., Pogodda, M., Proba, J. & Henze, G. (2001) Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia. Lancet, 358, 1239-1241.
15. Erba, E., Serafini, M., Gaipa, G., Tognon, G., Marchini, S., Celli, N., Rotilio, D., Broggini, M., Jimeno, J., Faircloth, G.T., Biondi, A. & D'Incalci, M. (2003) Effect of Aplidin in acute lymphoblastic leukaemia cells. British Journal of Cancer, 89, 763-773.
16. Feig, S.A., Harris, R.E. & Sather, H.N. (1997) Bone marrow transplantation versus chemotherapy for maintenance of second remission of childhood acute lymphoblastic leukemia: a study of the Children's Cancer Group (CCG-1884). Medical and Pediatric Oncology, 29, 534-540.
17. Gavnon, P.S., Qu, R.P., Chappell, R.J., Willoughby, M.L., Tubergen, D.G., Steinherz, P.G. & Trigg, M.E. (1998) Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse - the Children's Cancer Group Experience. Cancer, 82, 1387-1395.
18. Giona, F., Testi, A.M., Annino, L., Amadori, S., Arcese, W., Camera, A., Di Montezemolo, L.C., Ladogana, S., Liso, V. & Meloni, G. (1994) Treatment of primary refractory and relapsed acute lymphoblastic leukaemia in children and adults: the GIMEMA/AIEOP experience. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. Associazione Italiana Ematologia ed Ocologia Pediatrica. British Journal of Haematology, 86, 55-61.
19. Hann, I., Vora, A., Harrison, G., Harrison, C., Eden, O., Hill, F., Gibson, B. & Richards, S. (2001) Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol. British Journal of Haematology, 113, 103-114.
20. Harrison, G., Richards, S., Lawson, S., Darbyshire, P., Pinkerton, R., Stevens, R., Oakhill, A. & Eden, O.B. (2000) Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial. MRC Childhood Leukaemia Working Party. Annals of Oncology, 11, 999-1006.
21. Harrison, C.J., Martineau, M. & Seeker-Walker, L.M. (2001) The Leukaemia Research Fund/United Kingdom Cancer Cytogenetics Group Karyotype Database in acute lymphoblastic leukaemia: a valuable resource for patient management. British Journal of Haematology, 113, 3-10.
22. Henze, G., Fengler, R., Hartmann, R., Kornhuber, B., Janka-Schaub, G., Niethammer, D. & Riehm, H. (1991) Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group. Blood, 78, 1166-1172.
23. Jeha, S., Gandhi, V., Chan, K.W., McDonald, L., Ramirez, L, Madden, R., Rytting, M., Brandt, M., Keating, M., Plunkett, W. & Kantarjian, H. (2004) Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia. Blood, 103, 784-789.
24. Kaplan, E.M. & Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457-481.
25. Klingebiel, T., Handgretinger, R., Lang, P., Bader, P. & Niethammer, D. (2004) Haploidentical transplantation for acute lymphoblastic leukemia in childhood. Blood Reviews, 18, 181-192.
26. Klumper, E., Pieters, R., den Boer, M.L., Huismans, D.R., Loonen, A.H. & Veerman, A.J. (1995) In vitro anthracycline cross-resistance pattern in childhood acute lymphoblastic leukaemia. British Journal of Cancer, 71, 1188-1193.
27. Knechtli, C.J., Goulden, N.J., Hancock, J.P., Grandage, V.L., Harris, E.L., Garland, R.J., Jones, G.G., Rowbottom, A. W., Hunt, L.P., Green, A.F., Clarke, E., Lankester, A. W., Cornish, J.M., Pamphilon, D.H., Steward, G.G. & Oakhill, A. (1998) Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia. Blood, 92, 4072-4079.
28. Krejci, O., van der Velden, V.H., Bader, P., Kreyenberg, H., Goulden, N., Hancock, J., Schilham, M.W., Lankester, A., Revesz, T., Klingebiel, T. & van Dongen, J.J. (2003) Level of minimal residual disease prior to haematopoietic stem cell transplantation predicts prognosis in paediatric patients with acute lymphoblastic leukaemia: a report of the Pre-BMT MRD Study Group. Bone Marrow Transplantation, 32, 849-851.
29. Lawson, S.E., Harrison, G., Richards, S., Oakhill, A., Stevens, R., Eden, O.B. & Darbyshire, P.J. (2000) The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study. British Journal of Haematology, 108, 531-543.
30. Locatelli, P., Zecca, M., Messina, C., Rondelli, R., Lanino, E., Sacchi, N., Uderzo, C., Fagioli, F., Conter, V., Bonetti, F., Favre, C., Porta, F., Giorgiani, G. & Pession, A. (2002) Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors. Leukemia, 16, 2228-2237.
31. Loh, M.L., Silverman, L.B., Young, M.L., Neuberg, D., Golub, T.R., Sallan, S.E. & Gilliland, D.G. (1998) Incidence of TEL/AML1 fusion in children with relapsed acute lymphoblastic leukemia. Blood, 92, 4792-4797.
32. Messina, C., Valsecchi, M.G., Arico, M., Locatelli, F., Rossetti, F., Rondelli, R., Cesaro, S., Uderzo, C., Conter, V., Pession, A., Sotti, G., Loiacono, G., Santoro, N., Miniero, R., Dini, G., Favre, C., Meloni, G., Testi, A.M., Werner, B., Silvestri, D., Arrighini, A., Varotto, S., Pillon, M., Basso, G. & Zanesco, L. (1998) Autologous bone marrow transplantation for treatment of isolated central nervous system relapse of childhood acute lymphoblastic leukemia. AIEOP/FONOP-TMO group. Associzione Italiana Emato-Oncologia Pediatrica. Bone Marrow Transplantation, 21, 9-14.
33. Miniero, R., Saracco, P., Pastore, G., Zurlo, M.G., Terracini, B., Rosso, P. & Masera, G. (1995) Relapse after first cessation of therapy in childhood acute lymphoblastic leukemia: a 10-year follow-up study. Italian Association of Pediatric Hematology-Oncology (AIEOP). Medical and Pediatric Oncology, 24, 71-76.
34. Mitchell, C.D., Richards, S., Kinsey, S., Lilleyman, J., Vora, A. & Eden, O.B. (2004) Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of UK MRC trial ALL 97/99. Pediatric Blood and Cancer, 43, 348.
35. Mitelman, F. (1995) International System for Human Cytogenetic Nomenclature (1995). Karger, Memphis, TN.
36. O'Reilly, J., Meyer, B., Baker, D., Herrmann, R., Cannell, P. & Davies, J. (1995) Correlation of bone marrow minimal residual disease and apparent isolated extramedullary relapse in childhood acute lymphoblastic leukaemia. Leukemia, 9, 624-627.
37. Oakhill, A., Pamphilon, D.H., Potter, M.N., Steward, G.G., Goodman, S., Green, A., Goulden, P., Goulden, N.J., Hale, G., Waldmann, H. & Cornish, J.M. (1996) Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission. British Journal of Haematology, 94, 574-578.
38. Peto, R., Pike, M.C., Armitage, P., Breslow, N.B., Cox, D.R., Howard, S.V., Mantel, N., McPherson, K., Peto, J. & Smith, P.G. (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. British Journal of Cancer, 35, 1-39.
39. Ramakers-van Woerden, N.L., Pieters, R., Loonen, A.H., Hubeek, I., van Drunen, E., Beverloo, H.B., Slater, R.M., Harbott, J., Seyfarth, J., van Wering, E.R., Hahlen, K., Schmiegelow, K., Janka-Schaub, G.E. & Veerman, A.J. (2000) TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia. Blood, 96, 1094-1099.
40. Ritchey, A.K., Pollock, B.H., Lauer, S.J., Andejeski, Y., Barredo, J. & Buchanan, G.R. (1999) Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: a pediatric oncology group study. Journal of Clinical Oncology, 17, 3745-3752.
41. Rivera, G.K., Buchanan, G., Boyett, J.M., Camitta, B., Ochs, J., Kalwinsky, D., Amylon, M., Vietti, T.J. & Grist, W.M. (1986) Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse. A Pediatric Oncology Group Study. New England Journal of Medicine, 315, 273-278.
42. Rivera, G.K., Zhou, Y., Hancock, M.L., Gajjar, A., Rubnitz, J., Ribeiro, R.C., Sandlund, J.T., Hudson, M., Relling, M., Evans, W.E. & Pui, C.H. (2005) Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia. Cancer, 103, 368-376.
43. Rubnitz, J.E., Behm, F.G., Wichlan, D., Ryan, C., Sandlund, J.T., Ribeiro, R.C., Rivera, G.K., Hancock, M.L., Relling, M.V., Evans, W.E., Pui, C.H. & Downing, J.R. (1999) Low frequency of TEL-AML1 in relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroup. Leukemia, 13, 19-21.
44. Sadowitz, P.D., Smith, S.D., Shuster, J., Wharam, M.D., Buchanan, G.R. & Rivera, G.K. (1993) Treatment of late bone marrow relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood, 81, 602-609.
45. Schrappe, M., Camitta, B., Pui, C.H., Eden, T., Gaynon, P., Gustafsson, G., Janka-Schaub, G.E., Kamps, W., Masera, G., Sallan, S., Tsuchida, M. & Vilmer, E. (2000) Long-term results of large prospective trials in childhood acute lymphoblastic leukemia. Leukemia, 14, 2193-2194.
46. Schroeder, H., Garwicz, S., Kristinsson, J., Siimes, M.A., Wesenberg, F. & Gustafsson, G. (1995) Outcome after first relapse in children with acute lymphoblastic leukemia: a population-based study of 315 patients from the Nordic Society of Pediatric Hematology and Oncology (NOPHO). Medical and Pediatric Oncology, 25, 372-378.
47. Seeger, K., von Stackelberg, A., Taube, T., Buchwald, D., Korner, G., Suttorp, M., Dorffel, W., Tausch, W. & Henze, G. (2001) Relapse of TEL-AML1-positive acute lymphoblastic leukemia in childhood: a matched-pair analysis. Journal of Clinical Oncology, 19, 3188-3193.
48. Staal, F.J., van der Burg, M., Wessels, L.F., Barendregt, B.H., Baert, M.R., van den Burg, C.M., van Huffei, C., Langerak, A.W., van der Velden, V.H., Reinders, M.J. & van Dongen, J.J. (2003) DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: choice of technique and purification influence the identification of potential diagnostic markers. Leukemia, 17, 1324-1332.
49. Toms, J.R. (2004) CancerStats Monograph. Cancer Research UK, London, pp. 63-72.
50. Torres, A., Alvarez, M.A., Sanchez, J., Flores, R., Martinez, F., Gomez, P., Rojas, R., Herrera, C., Garcia, J.M., Andres, P., Velasco, F., Serrano, J., Roman, J., Rodriguez, A., Martin, C., Tabares, S., Rodriguez, J.M., Parody, R., Plaza, E., Leon, A., Romero, R., Jean-Paul, E., Prados, D., Aljama, R. & Fernandez, A. (1999) Allogeneic bone marrow transplantation vs chemotherapy for the treatment of childhood acute lymphoblastic leukaemia in second complete remission (revisited 10 years on). Bone Marrow Transplantation, 23, 1257-1260.
51. Uderzo, C., Grazia Zurlo, M., Adamoli, L., Zanesco, L., Arico, M., Calculli, G., Comelli, A., Cordero di Montezemolo, L., Di Tullio, M.T. & Guazzelli, C. (1990) Treatment of isolated testicular relapse in childhood acute lymphoblastic leukemia: an Italian multicenter study. Associazione Italiana Ematologia ed Oncologia Pediatrica. Journal of Clinical Oncology, 8, 672-677.
52. Uderzo, C., Dini, G., Locatelli, F., Miniero, R. & Tamaro, P. (2000) Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies. Haematologica, 85, 47-53.
53. Veys, P., Amrolia, P. & Rao, K. (2003) The role of haploidentical stem cell transplantation in the management of children with haematological disorders. British Journal of Haematology, 123, 193-206.
54. Volm, M., Zintl, F., Sauerbrey, A. & Koomagi, R. (1999) Proliferation and apoptosis in newly diagnosed and relapsed childhood acute lymphoblastic leukemia. Anticancer Research, 19, 4327-4331.
55. de Vries, M.J., Veerman, A.J. & Zwaan, C.M. (2004) Rituximab in three children with relapsed/refractory B-cell acute lymphoblastic leukaemia/Burkitt non-Hodgkin's lymphoma. British Journal of Haematology, 125, 414-415.
56. Wheeler, K., Richards, S., Bailey, C. & Chessells, J. (1998) Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience. Medical Research Council Working Party on Childhood Leukaemia. British Journal of Haematology, 101, 94-103.
57. Zwaan, C.M., Reinhardt, D., Jurgens, H., Huismans, D.R., Hahlen, K., Smith, O.P., Biondi, A., van Wering, E.R., Feingold, J. & Kaspers, G.J. (2003) Gemtuzumab ozogamicin in pediatric CD33-positive acute lymphoblastic leukemia: first clinical experiences and relation with cellular sensitivity to single agent calicheamicin. Leukemia, 17, 468-470.